Search results
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo Finance· 1 day agoThe sales contribution of Iovance’s other marketed cancer drug, Proleukin, is not likely to be...
The feds may reclassify marijuana. That could be a big deal for RI businesses.
Gannett via AOL· 9 hours agoAnother benefit: More clinical studies on marijuana Kim Ahern, chair of Rhode...Ahern: “If you talk...
Geisinger Health Plan and OncoHealth to provide comprehensive cancer support to members
WRBL Columbus· 4 hours agoGeisinger Health Plan (GHP) with OncoHealth®, the leading platform for managing the cost and complexity of cancer, will provide supportive cancer care services ...
Combo Therapy May Be Advance Against Liver Cancer
KTBS Shreveport· 1 day agoA new combination therapy appears to boost the response rate for liver cancer patients receiving immunotherapy, according to results from a phase 2...
Coach's death spotlights pharma's profit wins in chemo drug shortage
Salon via Yahoo News· 4 days agoJeff Bolle, 60, died on Dec. 29, 2023 of stage 4 bile duct cancer, seven months after his last...
Man diagnosed with stage 4 melanoma after this symptom
WJW via Yahoo News· 2 hours agoIt was in April of 2019 that Rob Nosanchuk, a senior rabbi at Fairmount Temple in Beachwood, said a...
Dow Jones Drug Giant Merck, Nvidia Eye Buy Points In Current Stock Market
Investor's Business Daily· 24 hours agoMerck stock backstory: On April 25, Merck jumped after the Dow Jones stalwart topped Wall Street's...
Onivyde dosage: Form, strength, how it’s given, and more
Medical News Today· 1 day agoOnivyde (irinotecan liposome) is a brand-name drug that’s prescribed for metastatic pancreatic ...
Southern Nevada oncologists struggling to treat cancer patients during drug shortage
FOX 5 Las Vegas· 7 days agoFor those who get a life-altering diagnosis such as cancer, people seek treatment. This has left...
Inflation’s hit to the FDA
Politico· 3 hours agoPeter Marks, head of the FDA’s Center for Biologics Evaluation and Research, said during a Friends of Cancer Research event in Washington. “Right now, it’s not a bad time ...
